FOXP3 and myeloid sarcoma: Moreover, deregulation of IL-2 pathway leads to altered proliferation and reduced Foxp3 expression in Treg cells from RR-MS subjects, and these parameters inversely correlate with disease clinical score (EDSS) (247).